The Assisted Reproductive Technology Market in 2023 is US$ 28.55 billion, and is expected to reach US$ 55.31 billion by 2031 at a CAGR of 8.60%.
FutureWise Research published a report that analyzes Assisted Reproductive Technology Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Assisted Reproductive Technology research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Assisted Reproductive Technology Market Sample
Assisted Reproductive Technology Market Segmentation:
By Procedure
- Fresh donor
- Fresh Non-donor
- Frozen Donor
- Frozen Nondonor
- Embryo/Egg Banking
By Technology
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination - Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Ovulation Induction (OI)
- Donor Conception
- Gamete Intrafallopian Transfer (GIFT)
- Preimplantation Genetic Diagnosis (PGD)
- Surrogacy
By Diagnosis
- Ovulation Testing
- Hysterosalpingography
- Ovarian Reserve Testing
- Genetic Testing
- Other hormone testing
- Imaging tests
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Gynecology Centers
- Feminist Health Centers
- IVF Centers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Major players included in the Assisted Reproductive Technology Market:
- Thermo Fisher Scientific, Inc.
- Genea Limited
- Cook Medical
- Nidacon International AB
- OvaScience Inc.
- Vitro Life
- Cooper Surgical Inc.
- Merck
- IVFtech ApS
- Irvine scientific
- Hamilton Thorne
- Cosmos Biomedical
- Microm UK Ltd.
- Origio
- Cryolab Ltd.
- Parallabs
- European Sperm Bank
- Bloom IVF Centre
- Ferring Pharmaceuticals
Please visit full report of the Assisted Reproductive Technology market @ Visit Assisted Reproductive Technology Market
Competitive Landscape:
- Tier one players - market players with a significant share of the market
- Tier two players
- Players with rapid growth
- New Entries
FutureWise Key Takeaways:
- Prospects for growth
- Analysis of SWOT
- Key trends
- Key Data-points affecting market growth
Objectives of the Study:
- To provide report with an in-depth analysis of the Assisted Reproductive Technology Market By Procedure, By Technology, By Diagnosis, By End User and By Region
- To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
- Analysis and forecasting of micro-markets, as well as the scope of the market.
- To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
- To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Flexible Delivery Model:
- With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
- Customization services are included with the purchase of any license type of report.
- Customization requests can be sent directly to: [email protected]
FutureWise Research:
Contact Person: Vinay T.
Email: [email protected]
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com
